Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic options
P Pastena, JT Frye, C Ho, ME Goldschmidt… - Heart Failure …, 2024 - Springer
Ischemic cardiomyopathy (ICM) is the most prevalent cause of heart failure (HF) in
developed countries, with significant morbidity and mortality, despite constant improvements …
developed countries, with significant morbidity and mortality, despite constant improvements …
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM …
M Metra, EA Jankowska, M Pagnesi… - European journal of …, 2022 - Wiley Online Library
Aims In AFFIRM‐AHF, intravenous ferric carboxymaltose (FCM) reduced heart failure (HF)
hospitalisations and improved quality of life versus placebo in iron‐deficient patients …
hospitalisations and improved quality of life versus placebo in iron‐deficient patients …
Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis
BS Rangwala, V Zuhair, MS Mustafa… - Future Science …, 2024 - Taylor & Francis
Aim: Iron deficiency (ID) is associated with heart failure (HF) in a considerable proportion of
patients. To improve the quality of life, lower the frequency of hospitalizations, and lower …
patients. To improve the quality of life, lower the frequency of hospitalizations, and lower …
Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3
CJ Reitz, M Tavassoli, DH Kim… - Proceedings of the …, 2023 - National Acad Sciences
The prognosis and treatment outcomes of heart failure (HF) patients rely heavily on disease
etiology, yet the majority of underlying signaling mechanisms are complex and not fully …
etiology, yet the majority of underlying signaling mechanisms are complex and not fully …
Ischemic cardiomyopathy versus non-ischemic dilated cardiomyopathy in patients with reduced ejection fraction—clinical characteristics and prognosis depending on …
A Tymińska, K Ozierański, P Balsam, C Maciejewski… - Biology, 2022 - mdpi.com
Simple Summary Given the high morbidity and mortality linked with heart failure and the
need for disease-specific treatment, there is international agreement that there is a …
need for disease-specific treatment, there is international agreement that there is a …
Network pharmacology analysis and experimental verification strategies reveal the action mechanism of danshen decoction in treating ischemic cardiomyopathy
M Liu, G Yuan, G Luo, X Guo, M Chen… - Evidence‐Based …, 2022 - Wiley Online Library
Background. Danshen Decoction comprises Salvia miltiorrhiza, Santalum album, and
Amomum villosum. It can promote blood circulation and remove blood stasis, and is …
Amomum villosum. It can promote blood circulation and remove blood stasis, and is …
Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation: a report from the GARFIELD-AF registry
R Corbalan, JP Bassand, L Illingworth… - JAMA …, 2019 - jamanetwork.com
Importance Congestive heart failure (CHF) is commonly associated with nonvalvular atrial
fibrillation (AF), and their combination may affect treatment strategies and outcomes …
fibrillation (AF), and their combination may affect treatment strategies and outcomes …
Left ventricular global longitudinal strain predicts elevated cardiac pressures and poor clinical outcomes in patients with non-ischemic dilated cardiomyopathy
I Kažukauskienė, G Balčiūnaitė, V Baltrūnienė… - Cardiovascular …, 2021 - Springer
Background Risk stratification in patients with non-ischemic dilated cardiomyopathy (NI-
DCM) is essential to treatment planning. Global longitudinal strain (GLS) predicts poor …
DCM) is essential to treatment planning. Global longitudinal strain (GLS) predicts poor …
Myocardial and serum galectin-3 expression dynamics marks post-myocardial infarction cardiac remodelling
Background Acute myocardial infarction (MI) causes significant changes in cardiac
morphology and function. Galectin-3 is a novel and potentially therapeutically important …
morphology and function. Galectin-3 is a novel and potentially therapeutically important …
Ischemic etiology in advanced heart failure: insight from the HELP-HF Registry
A Villaschi, M Pagnesi, D Stolfo, L Baldetti… - The American Journal of …, 2023 - Elsevier
In patients with advanced heart failure (HF), defined according to the presence of at least
one I-NEED-HELP criterium, the updated 2018 Heart Failure Association of the European …
one I-NEED-HELP criterium, the updated 2018 Heart Failure Association of the European …